ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
Conditions
Malignant Ovarian Epithelial Tumor · Platinum-Resistant Fallopian Tube Carcinoma · Platinum-Resistant Ovarian Carcinoma · Platinum-Resistant Primary Peritoneal Carcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma · Refractory Fallopian Tube Carcinoma · Refractory Ovarian Carcinoma · Refractory Primary Peritoneal Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Robert Morris, M.D. (Sub-investigator)Contact: Principal Investigator (Ira Winer, M.D.)Radhika Gogoi, M.D. (Sub-investigator)Karmanos Cancer Institute at McLaren Flint, Flint, Michigan, United States
Study leads
Ira Winer, M.D.
Principal Investigator
Barbara Ann Karmanos Institute